An international, randomised, double-blind, placebo-controlled, parallel group study to investigate whether a minimum of three doses of TroVax®, added to first-line standard of care therapy, prolongs the survival of patients with locally advanced or metastatic clear cell renal adenocarcinoma

2013 ◽  
Author(s):  
Robert Amato
Keyword(s):  
Clear Cell ◽  
Locally Advanced ◽  
Standard Of Care ◽  
First Line ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Renal Adenocarcinoma ◽  
Parallel Group Study ◽  
Parallel Group ◽  
Line Standard

Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of postoperative pain: A double-blind, placebo- and active-controlled parallel-group study

2004 ◽  
Vol 26 (12) ◽  
pp. 2003-2014 ◽  
Author(s):  
Thomas Van Dyke ◽  
Leonard J. Litkowski ◽  
Theodore A. Kiersch ◽  
Nooshin Majd Zarringhalam ◽  
Hongjie Zheng ◽  
...  
Keyword(s):  
Postoperative Pain ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Parallel Group Study ◽  
Parallel Group

A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers

1998 ◽  
Vol 176 (6) ◽  
pp. 27S-31S ◽  
Author(s):  
Claartje H.M van Nispen ◽  
Andy I.M Hoepelman ◽  
Marja Rozenberg-Arska ◽  
Jan Verhoef ◽  
Lynn Purkins ◽  
...  
Keyword(s):  
Healthy Male ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Healthy Male Volunteers ◽  
Male Volunteers ◽  
Parallel Group Study ◽  
Parallel Group
Sign in / Sign up

Export Citation Format

Share Document